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CHAPTER I 
INTRODUCTION 
Literature Review 
Bovine Pneumonic Pasteurellosis 
Bovine pneumonic pasteurellosis is a severe, acute, 
fibrinous bronchopneumonia and pleuritis. The disease most 
commonly occurs in beef cattle especially associated with 
the stress of transportation and is commonly called shipping 
fever. It is one of the component diseases of "the bovine 
respiratory disease complex" and continues to be one of the 
most significant disease problems of the cattle industry 
(Church and Radostits, 1981; Martin et al., 1980). 
Shipping fever is a multifactorial disease; factors 
required for onset of disease have not been well defined, 
but a compromised respiratory immunity in conjunction with 
bacteria that are potentially pathogenic to the lung are the 
two most common criteria. Pasteurella spp. are the most 
common bacteria isolated from animals suffering from 
shipping fever, and pneumonic pasteurellosis is the most 
common form of shipping fever. Stress and/or viral 
respiratory infections are frequent precursors to pneumonic 
2 
pasteurellosis because of their negative effect on the the 
immune system (Frank, 1986). Cattle stressors most 
associated with shipping fever are transport, overcrowding, 
and inclement weather especially with sudden temperature 
declines. Exposure to low temperature can cause decreased 
mucociliary clearance and increased deposition of pathogens 
into the lungs of calves (Diesel et al., 1991). Increased 
glucocorticoid release as a result of stress affects 
leukocyte function, and increased plasma cortisol levels in 
cattle as a result of transport have been documented (Filion 
et al., 1984; Roth, 1984). Because stress affects a variety 
of neuroendocrine functions which interact in a complex way 
with the immune system, the possibility of other negative 
effects on immunity is likely (Khansari et al., 1990). 
Virus-induced suppression of immunity can be due to 
local damage in the respiratory tract resulting in decreased 
microbial clearance as well as a direct effect on pulmonary 
leukocytes resulting in decreased phagocytosis (Yates, 
1982). Bovine respiratory viruses that have been associated 
with pneumonic pasteurellosis are bovine herpesvirus-1, 
parainfluenza virus-3, and bovine respiratory syncytial 
virus (Rosenquist, 1984; Dyer, 1981). Indirect suppression 
of immunity can also occur with viral infections. Bovine 
viral diarrhea (BVD) virus, although not a respiratory tract 
virus, has often been associated with respiratory disease by 
virtue of its general immunosuppressive effects (Potgieter, 
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1988; Richer et al., 1988). 
Mycoplasmas are another group of organisms that may 
contribute to pneumonic pasteurellosis. Because mycoplasmas 
are isolated so commonly from the upper and lower 
respiratory tracts of cattle with and without clinical 
pneumonia, their role is difficult to evaluate. Mycoplasma 
bovis and Mycoplasma dispar, the two most common isolates, 
potentially may be important underlying factors because they 
are capable of causing subclinical pneumonia and are 
immunosuppressive (Allen et al., 1992; Howard et al., 1987; 
Boothby et al., 1983; Bennett and Jaspar, 1977). 
Pasteurella haemolytica has been the most frequently 
and consistently isolated bacterium from the lungs of cattle 
that have died with shipping fever and is considered the 
major etiologic agent of pneumonic pasteurellosis (Shewen, 
1988; Frank and Smith, 1983; Jensen, 1976; Lillie, 1974). 
Haemophilus somnus is a less frequent isolate from acute 
pneumonic lungs. The role of Pasteurella multocida is less 
clear. It appears be more significant as a cause of 
pneumonia in young calves less than 6 months of age. It is 
frequently isolated from both nasal secretions and 
bronchoalvelolar lavage specimens in acute respiratory 
disease of feedlot calves. These isolations suggest that 
under field conditions, it may be less capable than P. 
haemolytica of causing severe pneumonia resulting in death 
in older calves (Allen et al. 1991). However, challenge of 
weanling calves with P. multocida results in pulmonary 
lesions similar, if not identical, to those caused by P. 
haemolytica (Ames, 1985; Panciera and Corstvet, 1984; 
Corstvet et al., 1978). 
Serovars of Pasteurella haemolytica 
Pasteurella haemolytica is a parasite of ruminants. 
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Its role in disease has been clarified somewhat by 
differentiating isolates into biovars and serovars. There 
are two biovars, A and T, based on differences in sugar 
fermentations with most A biotypes able to ferment arabinose 
but not trehalose and T biotypes able to ferment trehalose 
but not arabinose (Smith, 1961). Biotype is related to 
clinical disease in that T strains are causative agents of 
ovine septicemia in older lambs while A biotypes have been 
isolated from animals suffering from bovine and ovine 
pneumonic pasteurellosis and ovine mastitis (Adlam, 1989). 
Recent evidence from numerical taxonomic analysis and DNA-
DNA'hybridization supports the reclassification of the T 
biovar to a separate species, P. trehalosi (Sneath and 
Stevens, 1990). 
There are sixteen serovars of P. haemolytica based on 
capsular polysaccharides; serovars 3, 4, 10, and 15 are T 
biovars; the remaining 12 are A biovars (Fodor et al., 1988; 
Biberstein, 1960). Pasteurella haemolytica Al, (biovar A, 
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serovar 1), is the predominant isolate from the nasal 
passages of cattle with acute respiratory disease and from 
lungs of cattle that die from shipping fever (Purdy et al., 
1993 A; Frank, 1988). Other serotypes that are involved less 
frequently are as follows: A2, AS, A6, A7, A9, All, A12, and 
Al4 (Quirie et al., 1986; Reggiardo, 1979). 
In healthy, non-stressed cattle, P. haemolytica A2 is 
the serovar most frequently isolated from the nasal 
passages. When cattle are stressed or infected with a 
respiratory virus, a dramatic shift in the nasal flora 
occurs from serovar A2 to Al (Frank and Smith, 1983) with 
large numbers of Al colonizing the upper respiratory tract 
resulting in increased aerosolization of Al to the lower 
tract (Frank, 1988). The exact location of Al in carrier 
animals is unknown. Attempts to establish P. haemolytica Al 
in the ventral nasal meatus and the middle nasal meatus of 
calves have been unsuccessful (Frank et al., 1989; 1986). 
Tonsil colonization is a possibility but data are 
insufficient to support this location as a primary site 
(Frank and Briggs, 1992). 
Virulence Factors of Pasteurella haemolytica 
The factors that allow P. haemolytica Al to proliferate 
on the nasal mucosa are unknown. Loss of fibronectin, an 
adhesive glycoprotein, from upper respiratory tract 
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epithelial cell surfaces exposes receptors for gram-negative 
bacteria which increase their colonization (Woods, 1987). 
Loss of fibronectin in humans has been associated with 
stress. Leukocyte elastase has been identified as the 
enzyme that cleaves fibronectin from epithelial cells (Dal 
Nogare, 1987). In calves experimentally infected with P. 
haemolytica Al and IBR virus, increased nasal elastase 
activity was shown to precede bacterial colonization and 
decreased levels of elastase correlated with decreasing 
numbers of P. haemolytica Al in the nasal secretions (Briggs 
and Frank, 1992). These results suggest the presence of a 
specific receptor on P. haemolytica Al but not A2 that 
adheres to mucosal cells lacking fibronectin. 
Many gram-negative bacteria that colonize mucosal 
surfaces adhere via surface structures called pili or 
fimbriae. Although these hair-like appendages have been 
described on P. haemolytica (Morck et al., 1989; 1988; 
Potter et al.,1988), other researchers have been unable to 
demonstrate pili (Gonzalez et al., 1993; Confer et al., 
1990). Whether adherence is by pili or some other surface 
adhesin is controversial. 
Pasteurella haemolytica Al has a variety of virulence 
factors that contribute to infection and subsequent disease 
once the organism enters the lung. It should be noted that 
normal, unstressed calves rapidly clear the organism from 
the lungs. Stress and/or predisposing infections are 
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important for both nasal proliferation and establishment of 
the organism in the lungs. Corstvet et al. (1982) were the 
first to demonstrate a capsule on P. haemolytica Al and 
noted that a capsule was present on cells during the log 
phase of growth but diminished during the lag phase. 
Capsules may operate as virulence factors by preventing 
phagocytosis, by masking components such as LPS that 
activate the alternate complement pathway, or by restricting 
access of the complement membrane attack complex to the cell 
wall (Plaut, 1989; Brubaker, 1985). In vitro studies have 
shown that decapsulated P. haemolytica Al cells are more 
susceptible to complement-mediated serum killing and to 
phagocytosis by neutrophils (Chae et al., 1990). Capsular 
polysaccharide from P. haemolytica Al has been shown to 
directly affect bovine neutrophils in vitro resulting in 
decreased killing of ingested bacteria as well as decreased 
phagocytosis {Czuprynski et al., 1989). The presence of 
capsular material in the alveoli and on the bronchial 
surface of infected calf lungs (Whitely et al., 1990) and 
the lack of an inflammatory response to purified capsular 
polysaccharide in sheep lungs suggests that the capsule may 
serve to protect the organism from phagocytosis in the early 
stages of lung entry and/or may act as an adhesin in the 
lower airways (Brogden et al., 1989). 
Pasteurella haemolytica during log growth phase 
releases a leukotoxin which is cytotoxic to ruminant 
neutrophils and macrophages (Shewen and Wilkie,1985; 1982). 
The leukotoxin is a pore-forming cytolysin and has been 
demonstrated in all recognized serovars (Gentry et al., 
1988; Chang et al., 1987; Shewen and Wilkie, 1983). 
Leukotoxin has been demonstrated in association with 
degenerating leukocytes in the alveoli of calves 
experimentally infected with P. haemolytica Al (Whiteley et 
al., 1990). It is thought to play an important role in the 
pathogenesis of pneumonic pasteurellosis in two significant 
ways. Firstly, it contributes to the establishment of P. 
haemolytica in the lung by its direct toxic effect on 
pulmonary phagocytes, the major host defense against 
bacterial infection. Secondly, leukotoxin contributes to 
tissue damage indirectly by the release of lysosomal 
products from cytotoxin-damaged leukocytes which results in 
an enhanced inflammatory response in the lung (Clinkenbeard 
et al., 1990). 
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Lipopolysaccharide (LPS) or endotoxin found in the 
cell wall of P. haemolytica is·similar to that of other 
gram-negative bacteria and may play a major role in the lung 
lesions observed in pneumonic pasteurellosis. 
Vascular leakage as a result of endothelial damage is a 
possible mechanism to explain the rapid influx of 
neutrophils, fibrin deposition, edema, pulmonary hemorrhage, 
and vascular thrombosis seen in acute shipping fever 
(Brieder et al., 1990). There are two mechanisms by which 
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endotoxin may cause lung damage. One is by the activation 
of complement. Endotoxin is recognized as one of the 
initiators of the alternate complement system which, through 
a complex of interactions, results in inflammation, 
clotting, and leukocyte chemotaxis. A second means may be 
via a direct effct on bovine endothelium. There is in vitro 
evidence that LPS directly damages bovine endothelial cells 
(Brieder et al., 1990; Paulsen et al., 1989). In calves 
experimentally inoculated with P. haemolytica Al, LPS was 
localized in alveolar exudate, in endothelial cells, and in 
phagocytes located in the alveoli, in pulmonary interstitial 
tissue, and within capillaries (Whiteley et al., 1990). LPS 
from P. haemolytica Al has been shown to produce pulmonary 
hemorrhage, edema,_ and acute inflammation when given to 
calves via airway inoculation (Slocombe et al., 1990). 
Outer Membrane Proteins 
The cell envelope of P. haemolytica is typical of a 
gram-negative bacterium and is composed of an inner 
cytoplasmic membrane, a thin layer of peptidoglycan, and an 
outer membrane surrounded by a polysaccharide capsule. The 
outer membrane is an asymmetric bilayer in which the 
phospholipids of the outer layer are replaced by 
lipopolysaccharide molecules. Outer membranes contain an 
abundance of protein; there are usually from two to eight 
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major outer membrane proteins (OMPs) and a variety of minor 
proteins. The major outer membrane proteins are in high 
copy numbers making them the major source of bacterial cell 
protein (Hancock, 1991). 
One of the major types of OMP is porin protein. These 
proteins as trimers form channels or pores in the outer 
membrane allowing passage of small water-soluble molecules 
(including nutrients) and excluding a variety of large 
molecules including certain antibiotics, detergents, toxins, 
and degradative enzymes (Hancock, 1991; Osborn and Wu, 
1980). 
OmpA-like proteins constitute another major OMP class. 
These proteins, along with lipoproteins, anchor the outer 
membrane to the underlying peptidoglycan layer and are 
important structurally (Jeweltz et al., 1987). 
The outer membrane proteins of P. haemolytica were 
first described in serovar Al by Squire et al. (1984); by 
various extraction methods two major OMPs of 30 and 42 kDa 
molecular weight were demonstrated. Major OMPs of similar 
molecular weight (42, 30, and 16 kDa) have been described 
for P. haemolytica A2 (Donachie and Gilmour, 1988). More 
recent investigations have demonstrated OMPs for P. 
haemolytica Al of 18, 29-30, 39.5, 40.5, 42, 71, 77, 87, 
100, and 100.5 kDa (Davies et al., 1992; Confer and Durham, 
1992). Comparison of envelope and outer membrane proteins 
of P. haemolytica serovars 1 through 15 by SDS-PAGE 
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demonstrated distinctive differences between the A and T 
biovars and minor to moderate differences among serovars 
within each biovar (Rossmanith et al., 1991; Knights et al., 
1990; Thompson and Mould, 1975). 
The outer membrane is in contact with the environment 
and on its surface has receptors for binding a variety of 
substances. Of major importance relating to pathogenicity 
are receptors that bind iron-containing siderophores or 
iron-bound transferrin molecules. A major growth-limiting 
factor for invasive bacteria is iron, which for most 
bacteria is unobtainable from the host by virtue of iron 
chelation to the glycoproteins transferrin and lactoferrin. 
The importance of iron availability is emphasized by the 
evidence that many pathogenic strains of bacteria can be 
differentiated from nonpathogenic strains by the ability to 
obtain iron from host tissue and that host susceptibility to 
bacterial infection increases as iron availability 
increases. (Griffiths et al., 1988) . 
Three iron-repressible OMPs (100 kDa, 77kDa, and 71kDa) 
have been described in P. haemolytica Al (Morck et al., 
1991; Deneer and Potter, 1989). The 100 kDa protein has 
been identified as a transferrin receptor specific for 
bovine transferrin; it would not bind human, porcine, 
equine, or chicken transferrin (Ogunnariwo and Schryvers, 
1990). Calves infected with P. haemolytica Al produce sera 
that will react by Western immunoblot to the 100 kDa, 77 
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kDa, and 70 kDa protein bands indicating that these proteins 
are expressed in vivo (Deneer and Potter, 1989). 
A study comparing iron-repressible OMPs in serotypes 
1 through 12 showed that serotypes 2 through 12 also show an 
increase in the 71 and 77 kDa proteins under iron-restricted 
conditions, but the 100 kDa band is not produced by all 
serotypes (Deneer and Potter, 1989). There was antigenic 
cross-reactivity among the serotypes respective to the three 
proteins. A 100 kDa serotype-specific antigen has been 
cloned from P. haemolytica Al and shown to be a surface-
exposed OMP which is immunogenic in rabbits (Lo et al., 
1991). Whether this is the 100 kDa iron-repressible protein 
described by others has not been determined. A 35 kDa iron-
regulated protein associated with the periplasm has been 
described in P. haemolytica A2 (Lainson et al., 1991). 
Immunoblot studies have shown that sera from cattle 
resistant to experimental challenge to P. haemolytica Al 
react strongly to proteins of 86, 66, 51, 49, 34, 31, and 16 
kDa. Responses to the 86, 49, and 31 kDa proteins were 
considered most significant because of magnitude, constancy 
and relationship to protection (Mosier et al., 1989). A 
surface-exposed 30 kDa protein has been cloned from P. 
haemolytica Al; bovine antibodies to this protein correlated 
to resistance against experimental challenge (Craven et al., 
1991). Interestingly, rabbits inoculated with excised bands 
of the 30 kDa protein in polyacrylamide gels reacted to both 
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the 30 kDa and a 15 kDa protein which suggests that the 15 
kDa protein may be a cleavage product of the larger protein. 
Bacterial surface proteins are likely to be involved in 
the initial encounter of the bacterium with the host whether 
it be on the nasal mucosa or in the lung and are potential 
immunogens. Surface-exposed proteins of P. haemlytica Al 
identified by radioiodination of whole cells revealed 4 
major protein bands of 100 kDa, 45 kDa, 30 kDa, and 16 kDa. 
(Craven et al., 1991). Surface proteins of approximately 
54, 44, 42, 40, 38, 34, 33, 20, 19, 18, and <18 kDa of P. 
haemolytica A2 cells were identified -by a similar method 
(Knights et al., 1990). 
Immunity to Pneumonic Pasteurellosis 
Numerous vaccines have been used in an attempt to 
immunize cattle against pneumonic pasteurellosis (Mosier, 
Confer et al. 1989). Whole cell bacterins have been studied 
extensively often with equivocal results related in part to 
the various procedures used by different researchers for 
vaccine preparation and for inoculating and challenging 
cattle in vaccine studies. Generally bacterins have not 
conferred protection and in some cases have enhanced the 
disease (Confer, et al., 1985 B; Wilkie et al., 1980; Friend 
et al., 1977). ~lthough Jericho et al. (1990) were able to 
protect cattle against low-dose experimental infection using 
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a formalin-killed vaccine without adjuvant, others have 
demonstrated the necessity of adding particular adjuvants to 
bacterins to provide protection (Confer et'al., 1987;_ 
Cardella et al., 1987). Bacterins mixed with adjuvants 
that potentiate a cell-mediated response such as Freund's 
complete, Freund's incomplete or oil do enhance protection 
against experimental disease (Confer et al.,1987; Cardella 
et al., 1987). 
Live vaccines have proven to be efficacious in 
experimentally infected animals regardless of the route of 
inoculation (Corstvet et al., 1978; Newman et al., 1982, 
Confer et al., 1984; Panciera et al., 1984). Several 
commercial live vaccines have been marketed but inherent 
problems with live bacteria as vaccines negate their 
usefulness in the field (Zemen et al., 1993; Tizard, 1990; 
Wohler and Harris, 1990). 
Various antigenic components of P. haemolytica have 
been studied in an attempt to elucidate those which are 
important in stimulating a protective immune response in 
cattle in the hopes of incorporating these into an 
efficacious vaccine. Although LPS probably plays a major 
role in development of lesions of pneumonic pasteurellosis, 
serum antibodies to LPS have not been correlated to 
resistance (Confer et al., 1986). 
Leukotoxin has been promising as an immunogen because 
it is a protein capable of stimulating a good humeral 
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response, and it is possibly one of the factors contributing 
to the efficacy of live vaccines. Although early reports 
indicated that resistance to challenge was correlated to 
leukotoxin antibodies (Mosier et al., 1986; Gentry et al., 
1985 B; Cho et al., 1984;), additional studies have shown 
that leukotoxin titers are not correlated with protection, 
and animals with no detectable antibody to leukotoxin can be 
resistant to challenge (Purdy et al., 1993b; Jericho et al., 
1990; Confer et al., 1987). 
Early work using leukotoxin as a vaccine was hampered 
by the inability to obtain purified toxin for inoculation 
(Shewen et al., 1988). More recently it has been shown that 
recombinant leukotoxin (rLKT) was unable to enhance 
protection when used alone but did increase the efficacy of 
a "culture supernatant" vaccine when used as a supplement 
(Conlon et al., 1991). This supports the earlier evidence 
that leukotoxin antibodies alone are not protective.-
However it does indicate that antibodies to leukotoxin may 
contribute to resistance. 
Antibodies to capsular polysaccharide (CP) can be 
detected after natural infection and have been produced by 
vaccination with live P. haemolytica Al, whole cell 
bacterins, surface-extracted carbohydrate-protein antigens 
and CP (Tigges and Loan, 1993; McVeyet al., 1990; Confer et 
al., 1989). Vaccination with capsular polysaccharide by a 
novel method of injecting CP-impregnated agar beads 
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intrathoracically into the lungs of goats produced partial 
resistance to experimental challenge indicating that capsule 
carbohydrate is a potential immunizing agent (Purdy et al., 
1993 B). 
Vaccination of calves with carbohydrate-protein subunit 
(CPS) antigens of P. haemolytica Al significantly enhanced 
resistance to experimental challenge (Confer et al., 1989). 
The CPS antigens were extracted from the surface of whole 
cells and contained carbohydrate, presumed to be of capsular 
origin, and protein presumably from the outer membrane 
(Confer et al., 1989; Durham et al.,1986; Lessley et al., 
1985). Antibodies to CPS antigens have been consistently 
associated with resistance to pneumonic pasteurellosis 
(Confer et al., 1989; 1987; 1985 B). High antibody titers 
to the protein portion (periodate-resistant) of the 
preparation rather than carbohydrate antigens were 
significantly correlated to resistance (Confer et al., 
1989), indicating a potential role for OMPs as immunogens. 
Research Objectives 
The pathogenesis of bovine pneumonic pasteurellosis is 
complex and many aspects remain to be elucidated. 
Efficacious vaccines to protect cattle against the disease 
have yet to be developed. The role of various virulence 
factors are being studied relative to contribution to 
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pathogenicity and to value as immunogens for vaccine 
production. Outer membrane proteins have excellent 
potential as immunogens especially those that are surface 
exposed, although little information is available on their 
role in eliciting a protective immune response. Serovar 
differences are important in development of both bovine and 
ovine pneumonic pasteurellosis. The role of OMPs in this 
regard is not known. Certain OMPs may be conserved among 
the species; some of these may be important immunogens which 
could stimulate a protective response to all serovars. 
This research was undertaken to better understand the 
relationship of OMPs of Pasteurella haemolytica to immunity. 
The research objectives were as follows: 
1. Compare the outer membrane proteins of Pasteurella 
haemolytica serovars 1-15 by SDS-PAGE; determine surface 
OMPs by iodine labeling. 
2. Evaluate the ability of OMPs to enhance resistance 
against pneumonic pasteurellosis and to determine serovar 
cross-protection by vaccinating cattle with OMP-enriched 
fractions of serovar Al, with a similar serovar (A6), and 
with a dissimilar serovar (A9) followed by challenge with P. 
haemolytica Al. 
3. Correlate the immmune response to major OMPs with 
resistance against experimental bovine pneumonic 
pasteurellosis for the purpose of selecting OMPs that 
stimulate humeral antibodies correlated with resistance. 
CHAPTER II 
COMPARISON OF THE MAJOR OUTER MEMBRANE PROTEINS 
OF PASTEUERELLA HAEMOLYTICA 
SEROVARS 1-15 
Abstract 
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The Sarkosyl method of obtaining outer membrane 
proteins (OMPs) from Pasteurella haemolytica Al was more 
efficient and less laborious than separating membranes by 
sucrose gradient centrifugation. More OMPs were recovered 
and major OMPs were present in greater concentrations in the 
Sarkosyl-derived preparations. Therefore, OMPs of P. 
haemolytica serovars 1 through 15 (serovars 3, 4, 10, and 15 
being T biotypes and the remainder being A biotypes) were 
prepared by the Sarkosyl method and compared by SDS-PAGE. 
Serovars 1, 2, 5, 6, 7, 8, 11, and 12 which are A biovars 
had similar OMP profiles characterized by major OMPs of 30.5 
and 43 kDa. Biovar T strains were characterized by doublet 
protein bands in the 26-28 kDa region and a major OMP in the 
38-40 kDa range. Serovars 9, 13, and 14 which are also A 
biovars had profiles more consistent, although not 
identical, with the T biovars. A 43 kDa protein was present 
in all serovars although concentration was greater in the A 
biovars. Surface-exposed proteins of P. haemolytica Al 
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determined by 125!-labeling of whole cells were 94, 84, 53.5, 
49, 43, 41, 29.5, and 16 kDa. Iodine-labeling of serovars 
A2 and A6 which have similar OMP profiles by SDS-PAGE 
resulted in autoradiographs indistinguishable from Al. 
Introduction 
Pasteurella haemolytica is an important pathogen of 
cattle and sheep causing shipping fever or bovine pneumonic 
pasteurellosis in cattle and pneumonia and septicemia in 
sheep. Several virulence factors of P. haemolytica Al, the 
major etiologic agent of shipping fever, have been 
identified, but the pathogenesis of this complex disease and 
the roles of these factors in producing disease have not 
been elucidated. Outer membrane proteins (OMPs) of 
bacteria, especially those that are surface-exposed, may 
play a role in pathogenesis and may be immunogens useful as 
vaccine components. Although P. haemolytica Al is the 
predominant serovar associated with shipping fever, other 
serovars are occasionally isolated from animals with 
pneumonic pasteurellosis. This is certainly true in ovine 
pneumonic pasteurellosis where a variety of serovars have 
been isolated even though P. haemolytica A2 is found most 
often. Serovars may share common antigens associated with 
OMPs that might be cross-protective against disease when 
used in vaccines in sufficient concentration; however, in 
one study vaccines against heterologous serovars were not 
protective (Gilmour et al.; 1983). 
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The first part of this study is an evaluation of two 
methods, Sarkosyl extraction and sucrose gradient 
centrifugation, for obtaining OMPs from P. haemolytica. The 
second part of the study is to compare the outer membrane 
proteins of serovars 1 through 15 to identify proteins that 
might be useful as serovar cross-protective immunogens. The 
third part of this study is to determine the surface-exposed 
OMPs of three selected serovars to identify potentially 
important immunogens. 
Materials and Methods 
Bacterial Cultures 
Pasteurella haemolytica serovars 1 and 6 were 
originally isolated from feedlot calves. The other 13 
serovars and serovar-typing antisera were kindly supplied by 
Dr. G.H. Frank (National Animal Disease Center, Ames, IA). 
Serovar identifications were confirmed by the rapid plate 
agglutination test (Frank and Wessman, 1978). All strains 
were maintained by harvesting 6-hour cultures from brain 
heart infusion agar with 5% citrated bovine blood (BHIB 
agar), suspending the harvests in BHI (BHI) broth with 15% 
glycerol, and storing at -70 C until ready to use. All 
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bacteria were cultured at 35-37 Cina 5% CO2 atmosphere. 
Total Membrane Preparations 
Each serovar was cultured from BHI glycerol stock on 
BHIB agar to check for purity. Six-hour cultures on BHIB 
agar were harvested into sterile phosphate-buffered saline 
(PBSS) (0.01M, pH 7.4) and frozen at -20 C until harvested 
cells were determined to be pure. The cells were thawed, 
washed once in PBSS (13,000 X g, 20 min, 4 C), and 
resuspended in PBSS to approximately one-half the original 
volume. The washed, whole-cell preparation was frozen at -
20 C until ready to use. 
Pasteurella haemolytica Al cells were disrupted by two 
methods, passage through a French pressure cell and 
sonication as previously described (Simons et al., 1989). 
Serovars 2 through 15 were disrupted by sonication. Cell 
membranes were collected by centrifugation, washed and 
stored as previously described (Simons et al., 1989). 
Sucrose Gradient Ultracentrifugation 
The sucrose gradient ultracentrifugation method was a 
modification of techniques described by Squire et al. (1984) 
and Cline and Ryel (1971). Cell membrane preparations 
(French pressured and sonicated) of P. haemolytica Al were 
diluted with an equal volume of HEPES buffer (0.01 M; pH 
7.4), and 1.5 - 2.7 ml volumes were layered onto tubes 
containing the following sucrose concentrations in HEPES 
buffer to form a gradient: 30%, 35%, 40%, 45%, 50%, and 
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55%. Tubes were centrifuged at 141,000 X g (SW 28 rotor, 
L8-60MR Beckman Ultracentrifuge) for 2 hours. The upper two 
layers were removed with a Pasteur pipet, and then the 
membrane layer was removed and diluted with an equal volume 
of HEPES buffer. Membranes (3-4 ml) were layered onto new 
sucrose gradients and centrifuged at 121,000 X g for 18 
hours. Tubes were fractionated into 1 ml aliquots, and 
absorbance at 280 nm (A280 ) was measured on each fraction. 
Aliquots with high A280 readings collected from the bottom or 
high density area of the gradients were pooled and washed 3X 
by centrifugation in cold, sterile, distilled water at 
226,000 X g (55.2 Ti rotor, L8-60MR Beckman Ultracentrifuge) 
for 2 hours. The final pellets (outer membranes) were 
suspended in 1-4 ml of sterile, distilled water and held at 
4 C for use within 24 hours or at -20 C for longer storage. 
Sarkosyl Insoluble Outer Membrane Preparations 
Sonicated cell membrane preparations of all 15 serovars 
in addition to the French pressure cell preparation of Al 
were extracted with Sarkosyl. To an aliquot of each total 
membrane preparation, 2 times the volume of 0.5% sodium N-
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lauroylsarcosine (Sarkosyl; Sigma Chemical Co., St. Louis, 
MO) in 0.01M Tris buffer was added to solubilize inner 
membranes (Squire et al., 1984). The solution was mixed 
gently for 30 minutes at room temperature, and insoluble 
(outer) membranes were collected by centrifugation at 
226,000 X g for 70 minutes. The membranes were then washed 
3x in cold, sterile, distilled water. The final pellet, 
referred to as Sarkosyl-insoluble preparation (SKI), was 
resuspended in 1-4 ml of sterile, distilled water and stored 
at -20 C. SKI prepared from Al cells contained 15.3 ug of 
2-keto,3-deoxyoctulonic acid per 1.0 mg of total protein. 
Analysis of succinate hydrogenase activity (an inner 
membrane enzyme) indicated <l~ contamination of the SKI with 
inner membranes. 
Radioiodination of Surface Membrane Proteins 
Whole cell preparations of P. haemolytica serovars 1, 
2, and 6 were labeled with 125I following the procedures 
described by Leyh and Griffith (1992) and Richardson and 
Parker (1985) as was an SKI preparation of P. haemolytica 
Al. Whole cells were incubated 18 hours before harvesting, 
then washed twice with PBSS and resuspended in PBSS to 0.1 g 
(wet weight) per ml. One mCi Na125I (Amersham Corp., 
Arlington, IL) and 4 rinsed Iodo-beads (Pierce, Rockford, 
IL) in glass vials were allowed to react at room temperature 
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for 5 minutes. One ml of whole cell preparation was added 
to each vial and allowed to react for five minutes. Whole 
cell preparations were removed from the vials by pipet and 
washed 3X in PBSS containing 1 mg NaI per ml to remove 
unreacted 1~I by centrifugation at 6000 X g (Sorvall-SS 34 
rotor). Sarkosyl-insoluble membrane preparation was diluted 
with PBSS to 50 ug of protein per ml. Iodination was 
performed as with the whole cell preparations except that 
1.0 ml of SKI prep containing 50 ug protein was labeled 
using 1.0 mCi Na125 I and 2 Iodo-beads. SKI prep was removed 
from the reaction by pipet and added to a desalting column 
(Excellulose GF-5; Pierce, Rockford, IL) to remove unreacted 
1
~I. The first 5 ml void volume was diluted with PBSS 
containing 1.0 mg per ml NaI and centrifuged at 240,000 X g 
(55.2 Ti rotor, L8-60MR Beckman Ultracentrifuge) for 90 
minutes. Iodine-labeled preparations were stored at -20 C 
until ready to use. 
SDS-PAGE was done on the iodine-labeled preparations 
using 5 ug protein per lane of whole cell preparation and 
approximately 40,000 counts per minute (CPM) per lane of SKI 
preparation (Appendix Al). Counts per minute were determined 
by using a Micromedic Gammma Counter( Micromedic Systems, 
Inc, Horsham, PA). Kodak X-Omat XAR-2 film (Eastman Kodak 
Co., Rochester, NY) was exposed to dried, Coomassie blue-
stained gels at room temperature to detect protein-labeling 
patterns. 
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SDS-PAGE 
Discontinuous SDS-PAGE was performed using 4% stacking 
gels and 10 to 12% resolving gels (Simons et al., 1989). 
Unlabeled samples were adjusted to 1.0 mg protein per ml and 
solubilized in sample buffer at 100 C for 90 sec before 
loading onto gels. Gels were stained with Coomassie 
brilliant blue. Apparent molecular weights of proteins 
were determined by comparison of relative mobilities in gels 
to known standards (Weber and Osborn, 1969). 
Protein Assays 
Protein concentrations were determined by either BioRad 
Protein Assay (Bio-Rad Laboratories, Inc., Hercules. CA) or 
Pierce BCA Protein Assay (Pierce, Rockford, IL). 
Densitometry 
Dried gels were analyzed by densitometry (Model 620 
Video Densitometer; Bio-Rad) as described (Simons et al., 
1989). Data are expressed as total area (mm2 ) of each peak. 
Results 
Comparison of OMP Preparation Methods 
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Although two distinct bands could not be seen in 
either cell disruption preparation after sucrose gradient 
centrifugation~ two bands were demonstrated in the French 
Pressure cell preparation by fraction collection and 
absorption at 280 nm with the largest protein peak in the 
high density range of the gradient (Figure 1). Sucrose 
centrifugation of sonicated preparations. resulted in one 
protein peak similar in concentration and density to the 
high density peak observed in the French pressure cell 
preparation. Electrophoretic profiles of P. haemolytica Al 
membranes recovered by the two disruption methods were 
remarkably similar (Figure 2). 
Comparison of outer membranes obtained by Sarkosyl 
exraction and sucrose gradient centrifugation revealed 
concentration differences of most of the major proteins 
(Figure 2) which was confirmed by densitometry (Figure 3a 
and 3b and Appendix A.2). Three major proteins of 30.5, 
38.5, and 96 kDa, and three minor proteins of 37, 44.5, and 
49 kDa were obtained by both methods. Higher concentrations 
of all bands were obtained by Sarkosyl extraction except for 
the 96 kDa band which had approximately the same total area 
of optical density by both methods (Figure 3a and 3b). The 
SKI preparations had additional minor proteins at 82 kDa and 
62.5 kDa that were of low concentration in the sucrose 
gradient preparations. 
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Comparison of Serovar OMPS 
Outer membrane protein preparations of P. haemolytica 
serovars 1 through 15 were prepared by Sarkosyl extraction 
of sonicated cells and compared by SDS-PAGE (Figure 4a and 
4b). There were at least two major OMPs observed in all 
strains. Serovars 1, 2, 5, 6, 7, 8, 11, and 12 which are A 
biovars had similar major OMPs; the remaining A biovars (9, 
13, and 14) had unique protein band patterns. Serovars 3, 
4, 10, and 14 were similar in having a doublet band at 
approximately 26-28 kDa and, along with serovar 15, were 
distinguished by a major band in the 38-40 kDa range. 
Radioiodination of Surface Membrane Proteins 
Autoradiographs of whole cells of P. haemolytica 
serovars 1, 2, and 6 showed labeled protein bands that were 
indistinguishable (Figure 5). Proteins that were labeled 
and presumably surfac·e-exposed were approximately 94, 84, 
53.5, 49, 43, 41, 29.5, and 16 kDa. Intensity of labeling 
was greatest with the 29.5 kDa protein, followed by the 49 
and 43 kDa proteins. Only two major proteins, 29.5 and 43 
kDa, were labeled in the SKI preparation; proteins of 16 and 
94 kDa were minimally labeled. The 49 kDa band which was 
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Figure 1. Sucrose gradient centrifugation of cell 
membranes of Pasteurella haemolytica Al prepared by 
sonication or passage through a French pressure cell. 
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Figure 2. SDS-PAGE of outer membrane preparations 
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of Pasteurella haemolytica Al prepared by sonication 
(S) or French pressure cell (F) disruption followed by 
separation using Sarkosyl extraction (SK) or sucrose 
gradient centrifugation (SG). Molecular weight markers 
are on t he l eft and expressed in thousands. 
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Figure 3a. Densitometric analyses of SDS-PAGE gels of 
OMPs of Pasteurella haemolytica Al obtained by Sarkosyl 
extraction (SKI) or sucrose gradient centrifugation 
(SG). Cells were disrupted by passage through a French 
pressure cell (FPC). 
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Figure 3b. Densitometric analyses of SDS-PAGE gels of 
OMPs of Pasteurella haemolytica Al obtained by Sarkosyl 
extraction (SKI) or sucrose gradient centrifugatioon 
(SG). Cells were disrupted by sonication. 
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labeled in the whole cell preparation was noticeably absent 
in the SKI preparation. 
Discussion 
The Sarkosyl extraction method of obtaining outer 
membrane-enriched protein preparations was less laborious 
and resulted in higher concentrations of proteins than 
sucrose density gradient centrifugation. In addition, 
Squire et al. (1984) showed that this method is more 
effective than Triton-X 100 in the extraction of inner 
membrane proteins. 
Sarkosyl-derived outer membrane bands of 30.5, 37, 
38.5, 44.5, 49, 62.5, and 82 kDa are similar to those of 
previous reports. Several investigators have reported OMPs 
for P. haemolytica Al at approximately 18, 29-30, 39.5, 
40.5, 42, 71, 77, 87, 100, and 105 kDa (Davies et al., 1992; 
Confer and Durham, 1992; Squire et al., 1984). Iron-
repressible proteins (71, 77, and 100 kDa) were present but 
in small quantity as would be expected with the media used 
in these experiments in which iron was not restricted 
(Davies et al. 1992). 
Concentration of some bands varied and this was 
especially evident with the 38.5 kDa band. This band 
presented as a doublet with a less concentrated band of 37 
kDa. Stain variation, media differences, and incubation 
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time can alter expression of OMPs (Confer et al, 1992; 
Davies et al., 1992). Strain and incubation time were 
constant throughout the study. The same culture medium, BHI 
blood agar (Difeo), was used in these studies, although lot 
numbers did vary. The blood used to supplement the media 
was obtained from several different cattle. Whether the 
blood source affected OMP expression is not known, but it is 
worthy of future consideration. The amounts of proteins 
extracted by Sarkosyl might differ depending on the time of 
exposure to the detergent, the total volumes used, and the 
manner of mixing. Larger volumes may require longer 
exposure or different methods of mixing to ensure adequate 
extraction of inner membranes. In these experiments time of 
incubation with Sarkosyl and the mixing methods were 
constant, but total volumes varied greatly. 
Surface proteins of 16, 29.5, and 43 kDa detected by 
125!-labeling are similar to three previously reported for P. 
haemolytica Al of 15, 30, 45 by Craven et al. (1991). A 100 
kDa protein identified by Craven et al. (1991) as a surface 
protein was not evident in this experiment, although a high 
molecular weight protein (94 kDa) was labeled. Additional 
proteins labeled in this study and not previously reported 
for Al are 41, 49, 53.5, 84, and 94 kDa. Knights et al. 
(1990) reported that proteins of 92, 80, 73, 56.5, 53.5, 
43.5, 42.5, 39.5, 37.5, 34, 32.5, and 20.5 kDa were probably 
surface-exposed proteins of serovar 2, and they are probably 
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the same as the proteins labeled 94 (92), 84 (80), 53.5 
(53.5), 43 (43.5), 41 (42.5), and 29.5 (32.5) kDa in this 
experiment. 
Surface-exposed OMPs have the most potential for 
eliciting antibodies to enhance resistance to pneumonic 
pasteurellosis. Antibodies binding to surface proteins 
should result in opsonization and increased phagocytosis of 
the bacteria as well as initiating the classical complement 
pathway. The direct effect of antibody on function of 
surface proteins is not known; however, steric hindrance as 
a result of antibody attachment may be detrimental to the 
bacteria as a result of porin dysfunction, blocking of 
receptors for host cell adherence, or less effective iron 
uptake. 
The absence of labeled 49 kDa protein in the SKI 
preparation may be due to the overall lower concentrations 
of proteins in the SKI preparations in the gel, but a 49 kDa 
protein has been found consistently in SKI preparations of 
Al. Perhaps the tyrosine residues are better exposed on the 
whole cell than in the SKI preparations and are more 
accessible to iodine-labeling (Markwell, 1982). 
'Comparison of OMP profiles of P. haemolytica serovars 1 
through 15 demonstrated a protein of approximately 43 kDa; 
Although it varied in concentration, it was present in all 
15 serovars. This is likely the same protein as the 43 kDa 
that was found to be surface-exposed and may be a source of 
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serovar cross-protecting antigens. Serovars 1, 2, 5, 6, 7, 
8, 12 which are all A biovars had very similar profiles 
indicating that OMPs from these may be cross protective. 
Serovars 9 and 14 had unique profiles that were more similar 
to those of the T biovars, A9 having a major band of 26 kDa, 
A14 having the characteristic doublet at the 26-28 kDa 
range, and both having a major OMP in the 38-40 kDa range. 
These differences among some of the A biovars have not been 
reported previously and could result from strain variation, 
media differences, or differences in the stage of growth in 
which the cells were harvested (Davies et al., 1992; Confer 
and Durham, 1992; Rossmanith et al., 1991). In light of the 
various factors that affect OMP expression, comparisons of 
OMP profiles, especially among different investigators, is 
difficult and could be misleading. 
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Figure 4a. Outer membrane profiles of Pasteurella 
haemolytica serovars 1 through 15 demonstrating major 
bands. Molecular weight markers are on the right. 
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Figure 4b. Outer membrane proteins o f Pasteurella 
haemolytica serovars 1 through 15 demonstrating major 
and minor bands. Molecular weight markers are on 
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Figure 5. SDS-PAGE of radiolabeled whole cells of 
Pasteurella haemolytica serovars 2, 6, and 1, and 
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OMPs of serovar Al (SKI 1). Molecular weight markers 
are on the right . 
CHAPTER III 
VACCINATION OF CATTLE WITH OUTER MEMBRANE PROTEIN-
ENRICHED FRACTIONS OF PASTEURELLA HAEMOLYTICA 
AND RESISTANCE AGAINST EXPERIMENTAL CHALLENGE 
Abstract 
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A Sarkosyl-derived outer membrane protein (OMP) 
fraction of Pasteurella haemolytica Al (SKI-1) induced a 
protective response in calves against intrathoracic 
challenge with the homologous serovar. Outer membrane 
proteins from heterologous serovars, A6 and A9, induced 
partial protection that was associated with their respective 
similarities to Al in OMP profiles by SDS-PAGE. Calves 
vaccinated with SKI preparations did not have detectable 
neutralizing antibody to P. haemolytica Al leukotoxin. 
Antibodies to whole cell antigens and carbohydrate-protein 
subunit (CPS) antigen were associated with resistance which 
indicates that protein antigens shared among whole cell 
surface, CPS and SKI preparations are immunogenic and 
enhance resistance to experimental challenge. 
Introduction 
Shipping fever or bovine pneumonic pasteurellosis 
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continues to be one of the most significant disease problems 
of the cattle industry (Church and Radostits, 1981; Martin 
et al., 1980). Pasteurella haemolytica Al is the 
predominant organism associated with this complex disease, 
although other serovars are occasionally involved (Quirie et 
al., 1986; Reggiardo, 1979). Attempts to immunize cattle 
with P. haemolytica bacterins have been unrewarding. 
Various antigenic components of P. haemoltica have been 
studied in an attempt to determine those which are important 
in stimulating a protective_immune response in cattle. 
Vaccines that contain leukotoxin or capsular material have 
been shown to produce partial protection against 
experimental disease (Purdy et al. 1993b; Conlon et al., 
1991; Shewen and Wilkie 1988). 
Outer membrane proteins are potential candidates as 
immunogens especially those that are surface-exposed (Kimura 
et al., 1985; Gulig et al, 1982). Culture supernantants of 
logarithmic-phase P. haemolytica Al have been shown to 
enhance resistance against experimental pneumonia 
pasteurellosis which is serovar specific (Conlon et al., 
1991; Shewen and Wilkie, 1988). Although the supernatant 
contains a large amount of leukotoxin, it has been 
demonstrated that components other than leukotoxin are the 
responsible immunogens. The supernatant elicits agglutinins 
to whole cells of P. haemolytica indicating that some of the 
components are probably soluble cell surface antigens most 
likely from the outer membrane and capsule (Shewen and 
Wilkie, 1988). 
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Soluble surface antigens from whole cells of P. 
haemolytica extracted by saline, sodium salicylate, or 
potassium thiocyanate have been shown to enhance resistance 
to experimental infection (Confer et al., 1989; Yates et 
al., 1983; Gilmour et al., 1982). The antigens extracted by 
these methods are similar and most appear to be surface 
proteins in association with polysaccharide components 
(Durham et al., 1986). Antibodies to proteins in a 
carbohydrate-protein subunit (CPS) preparation of P. 
haemolytica Al have been associated consistently with 
resistance to pneumonic pasteurellosis (Confer, et al., 
1989; 1987; 1985). Carbohydrate-protein subunit antigen is 
an extract from the cell surface and presumably contains OMP 
suggesting that P. haemolytica Al OMPs may be capable of 
elicting a protective immune response to pneumonic 
pasteurellosis. 
The present study was undertaken to determine if an 
OMP-enriched preparation from P. haemolytica serovar Al when 
used as a vaccine could protect calves from experimental 
challenge and to ascertain possible cross-protection of OMPs 
using OMP-enriched fractions of serovars A6, which has a 
similar OMP profile as Al, and A9, which has a dissimilar 
OMP profile, as vaccines. 
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Materials and Methods 
Bacterial Cultures 
Pasteurella haemolytica Al and A9 were originally 
isolated from feedlot calves. Serovar 6 and serovar-typing 
antisera were obtained from Dr. Glynn Frank (National Animal 
Disease Center, Ames, Iowa). Serovar identifications were 
confirmed by the rapid plate agglutination test (Frank and 
Wessman, 1978). The strains used for outer membrane protein 
preparations were harvested from 6-hour growth on brain 
heart infusion agar with 5% citrated bovine blood (BHIB 
agar), suspended in brain heart infusion (BHI) broth with 
15% glycerol, and stored at -70 C until ready to use. 
Serovar 1 used as the challenge strain had been passaged 
periodically in calves, lyophilized, and stored at -20 C 
prior to use (Newman et al., 1982). 
Bacterial cell counts [colony forming units (CFU)] were 
estimated photometrically and confirmed by a spot-plate-
counting technique (Newman et al., 1982). 
Outer Membrane Protein-Enriched Preparations 
Pasteurella haemolytica serovars 1, 6, and 9 were 
cultured from the BHI glycerol stocks onto BHIB agar to 
check for purity. Six-hour cultures on BHIB agar were 
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harvested into sterile phosphate buffered saline solution 
(PBSS) (0.01M, pH 7.4) and frozen at -20 C until harvested 
cells were determined to be pure. The cells were thawed, 
washed once in PBSS (13,000 x g, 20 min, 4 C), and 
resuspended in PBSS to approximately one-half of the 
original volume. The washed, whole-cell preparations were 
frozen at -20 C until ready to use. Washed, whole-cell 
preparations of P. haemolytica were centrifuged at 20,000 x 
g for 20 min at 4 C, and the resulting pellets were weighed. 
Pellets were suspended in approximately 20 ml of 20% sucrose 
in 0.01 M HEPES bu£fer. RNase (Sigma Chemical Co., St. 
Louis, MO) and DNase (Sigma Chemical Co., St. Louis, MO) 
each were added at 1 mg per 4.2 gm (wet weight) of pellet. 
Bacterial cells were then sonicated (Simons et al., 1989), 
and the suspension was incubated at 37 C for 40 minutes. 
Remaining whole cells were removed by centrifugation at 6000 
x g for 20 minutes at 4 C. The supernatant was centrifuged 
at 226,000 x g (55.2 Ti rotor, L8-60MR Ultracentrifuge; 
Beckman Instruments, Inc.) for 70 minutes to collect the 
membranes, which were then washed 3 times in cold, sterile 
distilled water. The final pellet was suspended in 1-4 ml 
of sterile, distilled water and held at 4 C for use within 
24 hours or at -20 C for longer storage. 
To an aliquot of total membrane preparation, 2 times 
the volume of 0.5% sodium N-lauroylsarcosine (Sarkosyl; 
Sigma Chemical Co., St. Louis, MO) in 0.01M Tris buffer was 
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added to solubilize inner membranes (Squire et al., 1984). 
The solution was mixed gently for 30 minutes at room 
temperature, and insoluble (outer) membranes were collected 
by centrifugation at 226,000 x g for 70 minutes. The 
membranes were then washed 3 times in cold, sterile, 
distilled water. The final pellet, referred to as Sarkosyl-
insoluble preparation (SKI), was resuspended in 1-4 ml of 
sterile, distilled water and stored at -20 C. The SKI 
preparation contained 15.3 ug of 2-keto,3-deoxyoctulonic 
acid per 1.0 mg of total protein. Analysis of succinate 
hydrogenase activity (an inner membrane enzyme) indicated 
<1% contamination of the SKI with inner membranes. 
Vaccine Preparation 
All vaccinations were given in a 2.0 ml volume, 
subcutaneously in the caudal cervical region. The live 
vaccine was a 22-hour culture of P. haemolytica Al grown on 
BHIB agar, harvested ·into sterile PBSS, and adjusted to a 
density of approximately lxl0 9 CFU/ml (Panciera et al., 
1984). The outer membrane protein preparations were 
adjusted to 2.0 mg/ml of protein (Bio-Rad Protein Assay, 
BioRad Laboratories, Richmond, CA) and mixed with an equal 
volume of Freund's incomplete adjuvant (Difeo Laboratories, 
Detroit, MI). Two ml volumes of sterile PBSS were used as a 
negative vaccine control and were injected in the same 
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manner as the other vaccines. 
Serologic Evaluation 
Sera were tested for antibodies to P. haemolytica whole 
cell antigens by a quantitative fluorometric immunoassay 
(FIAX; Fluorescent Immunoassay System, International 
Diagnostic Technology Inc., Santa Clara, CA) as previously 
described (Confer et al., 1983). Titer equivalents were 
calculated for each sample by comparison with a standard 
curve constructed with sera of known end-point titers. 
Antibodies to carbohydrate-protein subunit antigen 
(CPS) were determined by an enzyme-linked immunosorbent 
assay (ELISA) as previously described (Confer et al., 1985a; 
Lessley et al., 1985). Carbohydrate-protein subunit antigen 
is a partially purified, high molecular weight saline 
extract of whole cells of P. haemolytica Al (Lessley et al., 
1985). Antibody responses are expressed as the absorbance 
at 490 nm for test sera minus the absorbance at 490 nm for 
PBSS. 
Serum titers to P. haemolytica leukotoxin were 
determined by a visual microtiter neutralization assay (LN) 
as previously described (Gentry et al., 1985a). Titers are 
expressed as the reciprocal of the highest serum dilution 
that neutralized leukotoxin. 
Calves 
Twenty-two crossbred male and female beef calves 
approximately 12-14 months old were obtained from a closed 
herd and transported to holding pens. Husbandry of the 
calves was as previously reported (Newman et al., 1982). 
Experimental Design 
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Prior to the start of the experiment (Day -16), sera 
from all calves were tested for the presence of antibodies 
to whole cell antigens of P. haemolytica Al by FIAX (Confer 
et al., 1983). Only calves with titers of <10 were used in 
the experiment. Calves were randomly assigned to the 
experimental groups. Live, unattenuated P. haemolytica Al 
was used as a positive vaccine control as it has been 
previously shown to provide protection against the 
experimental challenge method used (Panciera et al., 1984). 
Calves were challenge-exposed by intrathoracic inoculation 
of each caudal lung lobe (Panciera and Corstvet, 1984) with 
5 ml of a 22-hour culture of P. haemolytica Al grown on 
BHIB, harvested into sterile PBSS, and adjusted to a density 
of approximately l.Oxl0 9 CFU/ml. 
The 22 calves were divided into 5 groups and 
vaccinated on Days O and 7 as follows: Group 1 (5 calves), 
SKI-1 preparation; Group 2 (5 calves), SKI-6 preparation; 
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Group 3 (5 calves), SKI-9 preparation; Group 4 (5 calves), 
PBSS; and Group 5 (2 calves), live P. haemolytica Al. Sera 
were collected from all calves on Days 0, 7, 14, and 21. 
All serum samples were tested for antibodies by FIAX, 
ELISA, and LN tests. Calves were challenge-exposed on Day 
21 with 5.5xl0 9 CFU of P. haemolytica Al per caudal lung 
lobe. On Day 25 lung lesions were evaluated grossly and each 
calf was given a lung lesion score (0-20) based on a 
previously described scoring system wherein higher scores 
indicate less resistance to challenge (Panciera et al., 
1984). Calves that died from severe pneumonia after 
challenge were assigned a score of 20 because of the diffuse 
nature of the pulmonary lesions (Confer et al., 1987). 
Statistical Analysis 
All data are reported as mean± SD. ANOVA was used to 
compare means for more than 2 groups. Student's t-test was 
used to compare mean values between groups (Shott, 1990). 
The relationship between lesion score and antibody response 
was evaluated by obtaining a Pearson correlation for each 
and calculating at statistic to evaluate the linear 
association (Shott, 1990). AP value of< 0.05 was 
considered statistically significant. 
Results 
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The mean FIAX antibody titers for each vaccine group on 
Days 0, 71 14, and 21 are presented in Table 1, and 
individual titers are presented in Appendix B.1. Calves 
vaccinated with SKI-9 did not have an antibody response to 
the whole cell antigen; titers were not different from the 
PBSS controls. The calves vaccinated with live P. 
haemolytica Al responded with high titers. Calves vaccinated 
with SKI-1 and SKI-6 had moderate titers that were 
statistically different from the PBSS controls and the live 
vaccinates. There was a significant correlation between 
high FIAX titers and low lesion scores, both on an 
individual basis (r = -0.5844; P < 0.001) and on mean titers 
and lesion scores (r = -0.9228; P <0.05). 
The mean ELISA values for antibody to carbohydrate-
protein antigen are presented in Table 2, and individual 
values are presented in Appendix B.2. The SKI-1 calves were 
the only group to have values statistically different from 
the control group; however, the SKI-1 mean ELISA value was 
not statistically different from the mean value of the live 
vaccinate group. ELISA values in all groups, including the 
PBSS vaccinates, increased from Day 7 to Day 14 resulting in 
fairly high titers in the controls. High mean ELISA values 
of the vaccine groups were correlated with low mean lesion 
scores (r = -0.8379), although the correlation was not 
significant statisically nor demonstrated on an individual 
calf basis (r = -0.2428). 
Results of the leukotoxin-neutralization assay are 
presented in Table 3, and individual antibody titers are 
presented in Appendix B.3. Neutralizing antibody to 
leukotoxin was demonstrable only in the live vaccinates. 
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Mean lesion scores and antibody responses of each 
vaccine group at Day O and Day 21 are presented in Table 4, 
and individual calf lesion scores are presented in Appendix 
B.4. Mean lesion scores ranked from lowest to highest are 
as follows: live vaccinates< SKI-1< SKI-6 < SKI-9 < PBSS 
(Figure 1). Calves vaccinated with live P. haemolytica and 
SKI-1 had significantly lower lesion scores than the PBSS 
controls. 
Discussion 
The outer membrane protein preparation, SKI-1, induced 
a protective response in calves against challenge with the 
homologous serovar. The mean lesion score of the SKI-1 
vaccinates was significantly lower (P <0.05) than the PBSS 
control group demonstrating the presence of immunogenic, 
protective antigens in the outer membrane protein 
preparations. Antibodies to whole cell antigens and to 
carbohydrate-protein subunit antigens were associated with 
protection in the SKI-1 vaccinates. Both of these antigen 
preparations would be expected to have outer membrane 
proteins given that both contain components from the outer 
49 
layer of the organism. The degree of response to whole cell 
antigens (FIAX titers) was correlated with resistance to 
challenge. However, Confer et al., (1989) have previously 
demonstrated that bacterins elicit antibodies to whole cell 
antigens that are not correlated with resistance indicating 
that presence of whole cell antibodies merely indicates 
previous exposure to such antigens and is not a consistent 
indicator of resistance to infection. The mean antibody 
titer to whole cells of the live vaccinates was 
significantly greater than that of the SKI-1 vaccinates 
indicating that the SKI-1 preparation contains some, but not 
all, of the surface antigens found on whole cells. 
Mean antibody response to carbohydrate-protein subunit 
antigens was correlated with resistance to challenge. The 
correlation was not statistically significant due,in part, 
to the high ELISA values in the PBSS controls. Although the 
correlation was not demonstrable on individual calf data, 
perhaps because of animal to animal variation in antibody 
response, mean values were associated negatively with lesion 
scores. This observation is consistent with previous 
reports demonstrating that high antibody responses to 
carbohydrate-protein antigen are correlated with resistance 
to pneumonic pasteurellosis (Confer et al. 1989; 1987; 
1985a). It seems likely that the SKI-1 preparation, the 
carbohydrate-protein subunit, and surface components of 
whole cells share multiple antigens derived from outer 
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membrane proteins. Antibody responses to carbohydrate-
protein subunit which are correlated with resistance are 
predominantly against the protein portion some of which are 
surface-exposed (Confer et al., 1989; 1988) indicating that 
they are outer membrane proteins. 
Only the live vaccine induced neutralizing antibodies 
to leukotoxin indicating absence of leukotoxin in the OMP 
preparations. Some calves that lacked demonstrable 
leukotoxin antibodies were significantly resistant to 
challenge-exposure-which is further evidence that leukotoxin 
alone does not confer protection (Purdy et al., 1993b; 
Jericho et al., 1990; Confer et al., 1987) and possibly may 
play only a minor role in inducing resistance. 
The partial cross protection afforded by the 
heterologous serovars was of interest. 
resistance to greater degree than SKI-9. 
SKI-6 enhanced 
Although the mean 
lesion scores of SKI-6 and SKI-9 vaccinates were not 
significantly different from the PBSS controls, a trend was 
evident. The mean titers to whole cell antigens were nearly 
the same for SKI-1 and SKI-6 vaccinates indicating shared 
antigens to surface components which was not evident in the 
SKI-9 vaccinates. OMP profiles of SKI-1 and SKI-6 are very 
similar but differ considerably from SKI-9 indicating that 
although some OMPs are cross-reacting and capable of cross-
protection, certain OMPs are serovar specific, and both 
probably induce some protection against infection. 
Determination of specific OMPs and their role in 
resistance, as well as their ability to cross-protect, is 
needed in order to utilize specific OMPs as vaccine 
components. 
51 
Table I. Mean antibody response of calves to whole cell 
antigens as measured by quantitative fluorometric 
immunoassay (FIAX). Titers are expressed as 
geometric mean titers ± SD. 
Vaccine 
Group Day 0 Day 7 Day 14 Day 21 
Live 0.0 0.0 83.9 260.9 
(n=2l ± 0.0 ± 7.0 ± 1.7 ± 3.8 
PBSS 1.6 1.4 3.2 3.2 
{n=5) ± 2.8 ± 1.7 ± 4.2 ± 5.1 
SKl-1 0.0 3.8 15.2 24.4 
(n=5) ± 0.0 ± 3.5 ± 4.1 ± 3.2 
SKl-6 3.3 5.5 6.2 24.8 
(n=5) ± 3.5 ± 3.7 ± 9.0 ± 3.8 
SKl-9 3.0 2.4 2.7 2.4 
(n=5) ± 3.8 ± 3.4 ± 2.7 ± 3.3 
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Table II. Mean antibody response of calves to carbohydrate-protein 
antigen as measured by ELISA. Titers are mean absorbance 
at 490 nm ± SD. 
Vaccine 
Group Day 0 Day 7 Day 14 Day 21 
Live 0.409 0.743 1.277 1.414 
(n=2) ± 0.053 ± 0.053 ± 0.168 ± 0.272 
PBSS 0.435 0.453 0.900 0.827 
(n=5) ± 0.065 ± 0.354 ± 0.365 ± 0.164 
SKl-1 0.509 0.813 1.574 1.528 
(n=5) ± 0.157 ± 0.193 ± 0.494 ± 0.564 
SKl-6 0.317 0.314 0.792 1.094 
(n=5) ± 0.109 ± 0.216 ± 0.470 ± 0.293 
SKl-9 0.419 0.271 0.641 0.489 
(n=5) ± 0.158 ± 0.130 ± 0.262 ± 0.298 
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Table Ill. Mean antibody response of calves to leukotoxin as 
measured by visual leukotoxin-neutralization assay. Titers 
are expressed as geometric mean titers ± SD. 
Vaccine 
Group Day 0 Day 7 Day 14 Day 21 
Live 5.7 5.7 32.0 32.0 
(n=2l ± 1 .6 ± 1.6 ± 2.7 ± 2.7 
PBSS 1.5 1.3 1.5 3.5 
(n=5) ± 1.9 ± 1.4 ± 1.9 ± 2.1 
SKl-1 2.0 1.7 1.5 2.6 
(n=5) ± 2.7 ± 2.0 ± 1.4 ± 1.9 
SKl-6 1.5 1. 1 1 . 1 1.7 
(n=5l ± 1.7 ± 1.3 ± 1.3 ± 1.8 
SKl-9 2.0 2.0 2.0 3.0 
(n=Sl ± 2.0 ± 2.0 ± 1.6 ± 1.9 
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Table IV - Lesion scores and antibody responses of calves vaccinated with Pasteurella haemolytica outer membrane protein-enriched 
p__E~P~~ations (SKI-1, SKI-6, SKI-9), phosphate_buffered saline solution (PBSS), or live P. haemolytica serotype 1. 
Mean antibody response 
Carbohydrate-protein 
Whole cell antigen' subunit antigen' Leukotoxin1 
Vaccine Mean 
group (n) lesion score Day 0 Day 21 Day 0 Day 21 Day 0 Day 21 
SKI-1. (5) 5.3 ± 2.1* 1.0 ± 1.0 24.4 ± 3.2* 0.51, ± 0.18 1.53 ± 0.63* 2.0 ± 2.7 2.6 ± 1.9 
SKI-6 (5) 9.4 ± 6. 7 3.3 ± 4.1 24.8 ± 4.4* 0.32 ± 0.12 1.09 ± 0.33 1.5 ± 1.9 1.7±1.8 
SKI-9 (5) 12.2 ± 4.1 3.0 ± 4.4 2.4 ± 3.3 0.42 ± 0.18 0. 49 ± 0. 33 2.0 ± 2.0 3.0 ± 1.9 
PBSS (5) 15.0 ± 7.0 1.6 ± 2.8 3.2 ± 5.1 0.44 ± 0.07 0.83 ± 0.18 1.5 ± 1.6 3.5 ± 2.1 
Live (2) 2.3 ± 1.1* 1.0 ± 1.1 260.9 ± 3.8* 0.41 ± 0.08 1.41 ± 0.38 5.7±1.6 32.0 ± 2.7* 
*Significant difference from PBSS-inoculated group mean (P<0.05). 
'Geometric mean titer± SD as detected by quantitative fluorometric immunoassay (whole cell antigen) or visual 
leukotoxin-neutralization assay. 
fMean absorbance at 490nm ± SD as detected by ELISA; 
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CHAPTER IV 
OUTER MEMBRANE PROTEIN ANTIGENS OF PASTEURELLA HAEMOLYTICA 
ASSOCIATED WITH RESISTANCE TO PNEUMONIC PASTEURELLOSIS 
Abstract 
Irnmunoblotting data revealed that antibodies to outer 
membrane proteins of 84.5, 50.5, 45.5, 37, or 16.5 kDa from 
calves vaccinated with outer membrane protein-enriched 
fractions of Pasteurella haemolytica Al (SKI-1), A6 (SKI-6), 
or A9 (SKI-9) were significantly associated with resistance 
to experimental challenge. All three vaccines produced a 
similar antibody response to the 84.5 kDa protein while SKI-
1 and SKI-6 produced higher levels of antibodies as measured 
by densitometry to the 50.5, 37, and 16.5 kDa antigens than 
did the SKI-9 vaccine. SKI-1 produced higher antibody 
levels than either SKI-6 or SKI-9 to the 45.5 kDa protein. 
Irnmunoblots using sera from calves vaccinated with P. 
haemolytica bacterins or live organisms reacted against SKI-
1 antigens demonstrated that antibodies to outer membrane 
proteins of 82, 63, 45.5 and 29 kDa were significantly 
correlated to resistance. Based on these results, OMPs that 
appear to be protective irnmunogens are 45.5, 82-84.5, 16.5, 
37, 29, and 63 kDa. 
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Introduction 
Shipping fever or bovine pneumonic pasteurellosis 
continues to be one of the most significant disease problems 
of the cattle industry (Church and Radostits, 1981; Martin 
et al., 1980). Pasteurella haemolytica Al is the 
predominant organism associated with this complex disease, 
although other serovars are occasionally involved (Quirie et 
al., 1986; Reggardio, 1979). Various antigenic components 
of P. haemolytica have been studied in an attempt to 
elucidate those which are important in stimulating a 
protective immune response in cattle. Outer membrane 
protein-enriched fractions of P. haemolytica Al have been 
shown to protect cattle against experimental challenge 
(Chapter 3). Specific OMPs that are able to elicit 
antibodies that contribute to immunity have not been 
described. Previous studies have demonstrated association 
of resistance to experimental challenge to particular 
protein antigens in whole cell, leukotoxin, and 
carbohydrate-protein extract preparations of P. haemolytica 
Al by immunoblotting (Mosier et al., 1989b). This study was 
under taken in a similar manner to determine the outer 
membrane proteins to which antibodies are produced by 
vaccination with Sarkosyl-derived OMP-enriched fractions of 
P. haemolytica Al, A6, and A9, and to determine which 
antibodies are correlated with resistance to experimental 
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infection. 
Materials and Methods 
Bacterial Cultures 
Pasteurella haemolytica Al and A9 were originally 
isolated from feedlot calves. Serovar 6 and serovar-typing 
antisera were obtained from Dr. Glynn Frank (National Animal 
Disease Center, Ames, Iowa). Serovar identifications were 
confirmed by the rapid plate agglutination test (Frank and 
Wessman, 1978). The strains used for outer membrane protein 
preparations were harvested from 6-hour growth on brain 
heart infusion agar with 5% citrated bovine blood (BHIB 
agar), suspended in brain heart infusion (BHI) broth with 
15% glycerol, and stored at -70 C until ready to use. 
Serovar 1 used as the challenge strain had been passaged 
periodically in calves, lyopholized, and stored at -20 C 
prior to use (Newman et al., 1982). 
Outer Membrane Protein Enriched Fractions 
Pasteurella haemolytica serovars 1, 6, and 9 were 
cultured from the BHI glycerol stocks onto BHIB agar to 
check for purity. Six-hour cultures on BHIB agar were 
harvested into sterile phosphate buffered saline (PBSS) 
(0.01M, pH 7.4) and frozen at -20 C until harvested cells 
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were determined to be pure. The cells were thawed, washed 
once in PBSS (13,000 x g, 20 min, 4 C), and resuspended in 
PBSS to approximately one-half of the original volume. The 
washed, whole-cell preparations were frozen at -20 C until 
ready to use. Washed, whole-cell preparations of P. 
haemolytica were centrifuged at 20,000 x g for 20 min at 4 
C, and the resulting pellets were weighed. Pellets were 
suspended in approximately 20 ml of 20% sucrose in 0.01 M 
HEPES buffer. RNase (Sigma Chemical Co., St. Louis, MO) and 
DNase (Sigma Chemical Co., St. Louis, MO) each were added at 
1 mg per 4.2 gm pellet. Bacterial cells were then sonicated 
as previously reported (Simons et al., 1989), and the 
suspension was incubated at 37 C for 40 minutes. Remaining 
whole cells were removed by centrifugation at 6000 x g for 
20 minutes at 4 C. The supernatant was centrifuged at 
226,000 x g (55.2 Ti rotor, L8-60MR Ultracentrifuge; Beckman 
Instruments, Inc.) for 70 minutes to collect the membranes 
which were washed 3 times in cold, sterile, distilled water. 
The final pellet was suspended in 1-4 ml of sterile, 
distilled water and held at 4 C for use within 24 hours or 
at -20 C for longer storage. 
To an aliquot of total membrane preparation, 2 times 
the volume of 0.5% sodium N-lauroylsarcosine (Sarkosyl; 
Sigma Chemical Co., St. Louis, MO) in 0.01M Tris buffer was 
added to solubilize inner membranes (Squire et al., 1984). 
The solution was mixed gently for 30 minutes at room 
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temperature, and insoluble (outer) membranes were collected 
by centrifugation at 226,000 x g for 70 minutes. The 
membranes were then washed 3 times in cold, sterile 
distilled water. The final pellet, referred to as Sarkosyl-
insoluble preparation (SKI), was resuspended in 1-4 ml of 
sterile, distilled water and stored at -20 C. The SKI 
contained 15.3 ug of 2-keto,3-deoxyoctulonic acid per 1.0 mg 
of total protein. Analysis of succinate hydrogenase 
activity (an inner membrane enzyme) indicated <1% 
contamination of the SKI with inner membranes. 
Serum Samples and Lesion Scores 
Twenty-two serum samples from calves vaccinated with 
outer membrane protein-enriched fractions of P. haemolytica 
Al, A6, A9, PBSS, or live Al bacteria were used in the 
first part of this study (Chapter III). Each calf was 
inoculated subcutaneously twice, one week apart, with 2.0 ml 
of vaccine. Each OMP.vaccine aliquot contained Sarkosyl-
derived outer membrane protein preparation (2 mg protein) 
mixed with an equal volume of Freund's incomplete adjuvant 
(Difeo Laboratories, Detroit, MI). Serum was collected two 
weeks after the last vaccination which was the time of 
experimental challenge. The live vaccine was a 22-hour 
culture of P. haemolytica Al adjusted to a density of 
approximately 1 x 10 9 CFU/ml (Panciera et al., 1984). The 
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number of calves in each group were as follows: Al= 5, A6 = 
5, A9 = 5, PBSS (negative control) = 5, and live Al= 2. 
This group of calves was experimentally challenged 
intrathoracically with P. haemolytica Al (Panciera and 
Corstvet, 1984) the day the serum was collected (Day 21). 
Pulmonary lesions were evaluated grossly, and each calf was 
given a lung lesion score (0-20) based on a previously 
described scoring system wherein higher scores indicate less 
resistance to challenge (Panciera et al., 1984). 
An additional 40 serum samples were obtained from 
calves from a previous experiment that had been vaccinated 
with either PBSS (n=lO), P. haemolytica Al bacterin in 
Freund's incomplete adjuvant (FIA) (n=lO), P. haemolytica Al 
bacterin in aluminum hydroxide adjuvant (ALH) (n = 10), or 
live Al (n = 10) as previously described (Mosier et al., 
1989b). These calves were challenged and lung lesions 
scored in the same manner as described above. 
Immunoblots 
Sarkosyl insoluble preparations of P. haemolytica Al 
were adjusted to 1.0 mg protein per ml and solubilized in 
sample buffer containing sodium dodecyl sulfate at 100 C for 
90 sec before loading on gels. Four per cent polyacrylamide 
stacking gels and 10% resolving gels were used to separate 
proteins (Simons et al., 1989). Proteins from the gels were 
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transferred electrophoretically onto nitrocellulose 
membranes (Kirkegaard and Perry Laboratories, Inc., 
Gaithersburg, MD) which were cut into strips for 
immunoblotting. Each calf serum was diluted 1:25 and 
reacted with individual membrane strips for 1 hr. The 
strips were washed twice and Protein A-biotin diluted 1:400 
was added to each strip and allowed to react for 1 hr 
followed by two washes. Protein A was used instead of a 
secondary antibody to bind to IgG immunoglobulin. 
Streptavidin-horseradish peroxidase (Amersham Corp., 
Arlington Heights, IL) diluted 1:300 was added and allowed 
to react for 30 minutes. Color was developed with 4-chloro-
2-naphthol and hydrogen peroxide. Apparent molecular 
weights of proteins were determined by comparison of 
relative mobilities to that of known standards (Weber and 
Osborn, 1969). 
Densitometry 
Air-dried membrane strips were analyzed by densitometry 
(model 620 Video Densitometer; Bio-Rad) as described (Simons 
et al., 1989). Data are expressed as total area (mm2 ) of 
each peak. 
Statistical Analysis 
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The relationship between lesion score and optical 
density of each major protein band was evaluated by 
obtaining a Pearson correlation coefficient for each and 
calculating at statistic to evaluate the linear association 
between them (Shott, 1990). Student's t-test was used to 
compare mean optical densities of the major protein bands of 
the various vaccine groups. The mean lesion score of calves 
that had antibody for each protein band was compared by 
Student's t-test (Shott, 1990) to the mean lesion score of 
calves without detectable antibody. AP value of< 0.05 was 
considered statistically significant. 
Results 
Outer Membrane Protein-Enriched Vaccinated Calves 
Vaccination of calves with outer membrane protein-
enriched preparations of serovars 1, 6, and 9 and live P. 
haemolytica Al resulted in IgG antibodies that reacted with 
at least 12 different outer membrane proteins as detected by 
immunoblotting. The major proteins identified were 84.5, 72, 
64.5, 61, 57, 50.5, 45.5, 41, 37, 32, 27, and 16.5 kDa. 
There was no correlation betweeen any protein and resistance 
as measured by lesion score relationship to total peak area 
(Table I). 
The mean lesion scores for each group of sera with 
65 
antibodies versus the mean lesion score for the group 
without antibodies are presented in Table II. Calves with 
detectable antibodies to proteins of 84.5, 50.5, 45.5, 37, 
or 16.5 kDa had significantly lower lesion scores than those 
calves that lacked detectable antibody on immunoblots. 
Mean values for protein peak areas of each vaccine 
group is presented in Appendix C.l. The mean peak area of 
antibodies from calves vaccinated with SKI-1 were 
significantly greater than the PBSS controls to the 84.5, 
61, and 37 kDa bands. Sera from the SKI-6 vaccinates had 
significantly greater peak areas than the PBSS controls to 
the 37 and 32 kDa bands. Sera from the SKI-9 vaccinates had 
significantly greater peak areas to the 84.5 and 32 kDa 
bands than the PBSS controls. SKI-1 vaccinates had 
antibodies to protein bands with mean peak areas that were 
greater than SKI-6, SKI-9, or PBSS vaccinates at 72, 61, 57, 
45.5 and 41 kDa although. differences were _not statistically 
significant. Sera from SKI-1 and SKI-6 vaccinates both had 
greater peak areas than SKI-9 and PBSS vaccinates at 50.5, 
37, and 16.5 kDa bands, although only the 37 kDa band 
difference was statistically significant. SKI-1 vaccinates 
were unique in producing antibodies to 57 and 41 kDa 
proteins. 
Bacterin With Adjuvant-Vaccinated Calves 
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Vaccination of calves with bacterins of P. haemolytica 
Al with Freund's incomplete adjuvant or aluminum hydroxide 
adjuvant or with live bacteria resulted in antibodies to 6 
outer membrane protein bands at 82, 63, 45.5, 30.5, 29, and 
15 kDa. High antibody responses to protein bands at 82, 63, 
and 45.5 kDa correlated with low lesion scores in a linear 
fashion (Table III and Figure 1). 
The mean lesion score for each group of calves whose 
sera contained antibodies was significantly different from 
the mean lesion score of the group without detectable 
antibodies to the 82, 63, 45.5, and 29 kDa protein bands 
(Table IV). 
Discussion 
Vaccination of ca.lves with Sarkosyl-derived outer 
membrane protein preparations (SKI) has been shown to 
enhance resistance to experimental challenge with homologous 
serovars (Chapter III). The results of that study and 
others (Confer et al., 1989) have demonstrated an 
association of protection against pneumonic pasteurellosis 
with antibodies to proteins derived from a surface-extracted 
preparation which presumably contains outer membrane 
proteins. By immunoblotting sera from calves vaccinated 
with SKI-1, SKI-6 or SKI-9 to membran~s with separated 
proteins from SKI-1, antibodies to 12 protein bands were 
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demonstrated. Although the magnitude of the antibody 
repsonse to none of these bands could be correlated to 
resistance, the presence or absence of antibodies to 
particular bands was correlated with resistance as measured 
by comparing mean lesion scores of those with antibody to 
those sera without antibody. This observation suggests that 
mere presence of antibodies may be more significant than 
quantity of antibodies. Antibodies positively correlated 
with resistance by this method were to OMPs of 84.5, 50.5, 
45.5, 37, and 16.5 kDa. Mosier et al. (1989b), in a study 
using similar sera in immunoblots against whole cell, CPS, 
and leukotoxin antigen preparations, found that antibodies 
to 86, 51, 34, 31, and 16 kDA of whole cell and CPS antigens 
were significantly related to resistance. These may be the 
same as the 84.5, 50.5, and 16.5 kDa antigens detected in 
this study. Possibly the 34 and 37 kDa antigens are the 
same. Some discrepancy occurred in 43-49 kDa range, and it 
would be difficult to determine if the two studies were 
detecting the same bands or not. 
SKI-1 elicited antibody responses that were unique or 
greatly enhanced to 72, 61, 57, 45.5, and 41 kDa proteins. 
SKI-1 and SkI-6 elicited increased antibodies compared to 
SKI-9 vaccinates to 50.5, 37, and 16.5 kDa antigens. All 
three SKI vaccines elicited antibodies to 84.5 and 32 kDa 
proteins. 
Sera from bacterin-vaccinated calves had fewer bands on 
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immunoblots than did those of the SKI-vaccinated calves. 
This was expected given that the SKI-preparations have 
greatly increased amounts of OMPs relative to the bacterins, 
and SKI preps may have certain epitopes displayed that are 
masked in the bacterins. Antibodies to proteins of 82, 63, 
45.5, and 29 were correlated significantly with protection. 
Mean lesion scores of calves from groups with antibody were 
significantly lower than calves without antibody to each of 
these same four proteins. The 82 kDa protein is assumed to 
be the same as the 84.5 kDa antigen demonstrated in the 
first study. Thus, antibodies to the 82-84.5 and 45.5 kDa 
again appear to be significantly related to resistance. 
Bacterins and SKI preparations both elicit antibodies 
to OMPS of 82-84.5, 63-64.5, 45.5, 30.5-32, 27-29 and 15-
16.5 kDa. In addition SKI fractions elicited antibodies to 
72, 61, 57 50.5, 41, and 37 kDa that were not detectable in 
sera from bacterin-vaccinates in this study. Of these, 
antibodies to the 50.5 and 37 kDa antigens were associated 
with enhanced resistance. 
The failure to demonstrate a correlation of protein 
peak area to resistance in the Sarkosyl-inoculated calves 
may be due to the smaller number of calves used in that 
study. Variability between individual calves within each 
vaccine group was large and use of increased numbers of 
animals should help to alleviate the variability problem. 
Differences noted between estimated molecuar weights of 
69 
protein bands detected in each study may be due in part to 
slight changes in relative mobility rf measurements and in 
molecular weight markers used. Using 10% acrylamide gels 
makes estimation of molecular weights in the higher range of 
80 kDa to >lOOkDa extremely vulnerable to error as very 
slight changes in rt can result in major changes in apparent 
molecular weight. 
Outer membrane proteins of P. haemolytica Al that have 
been shown to be surface exposed are 94, 84, 53.5, 49, 43, 
41, 29.5, and 16 kDa (Craven et al., 1991; Chapter II). 
Antibodies to the OMPs that correlate positively with 
resistance in this study and that are probably surface-
exposed are 84.5, 50.5, 45.5, 29, and 16.5 kDa. These OMPs 
are worthy of continued study as potential components of 
efficacious vaccines for pneumonic pasteurellosis. 
Problems of identification of protein bands from one gel or 
blot to another may be alleviated by the use of monoclonal 
antibodies. Such an approach would be especially helpful in 
identifying proteins in ranges where there are several bands 
migrating within close proximity to one another. 
Table I. Correlation of peak area and 
lesion score for SKI-vaccinated 
calves. 
Band MW 
{kDa} r* 
84.5 - 0.1163 
72.0 - 0.2929 
64.5 - 0.4401 
61.0 - 0.2887 
57.0 - 0.3406 
50.5 - 0.2308 
45.5 - 0.4068 
41.0 - 0.1979 
37.0 - 0.4030 
32.0 - 0.0203 
27.0 - 0.2252 
16.5 + 0.0576 
* Pearson correlation coefficient. 
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Table II. Mean lesion scores for SKI-vaccinated 
calves with antibodies versus those 
without detectable antibodies to the 
various protein bands. 
Mean Lesion Scores 
Antibody Antibody 
Band Detected (n) Not Detected (n) 
84.5* 7.3 ± 5.4 (12) 12.6 ± 6.5 (10) 
72.0 8.9 ± 6.2 ( 6) 10.0 ± 6.6(16) 
64.5 10.2 ± 7.1 (13) 9.1 ± 5.4 ( 9) 
61.0 9.5 ± 6.2 (12) 10.1 ±6.8(10) 
57.0 7.8 ± 5.1 (12) 12.0 ± 7.2 (10) 
50.5 7.6 ± 6.2 (15) 14.3 ± 3.8 ( 7) 
45.5* 8.0 ± 5.8 (16) 14.3 ± 5.8 ( 6) 
41.0 7.6 ± 5.9 ( 8) 10.9 ± 6.5 (14) 
37.0* 6.8 ± 5.1 (14) 14.9 ± 4.9 ( 8) 
32.0 7.5 ± 5.7 (12) 12.4 ± 6.3 (10) 
27.0 9.9 ± 7.2 ( 8) 9.6 ± 6.1 (14) 
16.5* 6.0 ± 5.1 (11) 13.4±5.3(11) 
* Difference between mean lesion scores 
(p<0.05). 
71 
Table Ill. Correlation of peak area and 
lesion score for bacterin-
vaccinated calves. 
Band MW 
(kDa) r* 
82.0 -0.4665** 
63.0 -0.4249** 
45.5 -0.3266** 
30.5 -0.0851 
29.0 -0.1733 
15.0 -0.1329 
* r = Pearson correlation coefficient. 
**Indicates linear relationship (p<0.05). 
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Figure 1. Optical density of antibodies to 82, 63, and 45.5 
kDa proteins and lesion scores of bacterin-vaccinated 
calves. 
Table IV. Mean lesion scores for bacterin-
vaccinated calves with antibodies 
versus those without detectable 
antibodies to the various protein 
bands. 
Mean Lesion Scores 
Antibody Antibody 
Band Detected (n) Not Detected (n) 
82.0* 6.4 ± 5.9 (23) 11.6 ± 6.3 (17) 
63.0* 7.1 ± 6.0 (33) 15.1 ± 5.0 ( 7) 
45.5* 7.3 ± 6.1 (32) 13.7 ± 6.3 ( 8) 
30.5 6.7 ± 5.5 (16) 9.8 ± 7.0 (24) 
29.0* 6.2 ± 5.8 (23) 11.7 ± 6.4 (17) 
15.0 7.1 ± 6.2 (20) 10.0 ± 6.8 (20) 
* Difference between mean lesion scores 
(p<0.05). 
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APPENDIX 
Appendix A.1 
Counts per minute (CPM) and protein concentration 
of 1251-labeled samples used in autoradiography 
Sample 
P. haemolytica A 1 
P. haemolytica A2 
P. haemolytica A6 
SKl-1 
Protein (µg) 
5.00 
5.00 
5.00 
0.04 
CPM 
163,318 
53,190 
87,603 
40,005 
87 
Appendix A.2 88 
Mean peak area of outer membrane protein-enriched fractions 
Peak Area Optical Density 
Peak MW 
No. (kDa) FPC/SKI* FPC/SG* SON/SKI** SON/SG** 
1 96.0 2.591 2.512 2.678 2.078 
2 82.0 1.105 0.672 1.568 0.600 
3 69.0 0.980 0.599 1.053 0.417 
4 62.5 2.495 1.104 2.359 1.348 
5 57.5 0.764 0.906 0.540 0.873 
6 52.5 0.421 0.405 0.832 0.250 
7 49.0 1.590 1.179 1.829 1.372 
8 44.5 2.474 1.632 2.368 1.484 
9 42.0 0.583 0.504 0.789 0.464 
10 38.5 3.345 2.969 3.486 2.608 
11 37.0 1.244 0.565 0.921 0.547 
12 36.0 0.404 0.552 0.674 0.603 
13 34.5 1.521 1.053 1.573 1.009 
14 32.5 0.943 0.867 0.987 0.605 
15 30.5 4.544 3.924 4.576 3.520 
16 26.5 1.534 1.337 1.911 1.270 
17 23.5 1.899 1.241 1.830 1.218 
18 22.2 1.313 0.947 1.525 1.122 
19 20.5 2.191 2.814 2.808 2.414 
20 17.5 2.283 2.442 2.804 2.425 
21 16.0 2.879 1.705 2.914 1.847 
22 14.0 2.792 2.341 2.702 2.388 
*n = 2 
**n = 3 
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Antibody response of individual calves to whole cell antigens as 
measured by quantitative fluorometric immunoassay (FIAX) 
Vaccine Calf 
Group No. Day 0 Day 7 Day 14 Day 21 
Live 303 0.0 1.5 145.6 673.4 
313 0.0 72.8 48.3 101.1 
PBSS 300 0.0 0.0 17.2 27.2 
312 10.0 0.0 0.0 0.0 
317 0.0 1.5 20.1 0.0 
319 0.0 0.0 0.0 0.0 
H15 0.0 3.7 0.0 12.5 
SKl-1 299 0.0 9.5 51.5 84.9 
301 0.0 0.1 35.3 27.2 
309 0.0 24.2 23.2 22.5 
314 0.0 0.0 0.0 3.8 
322 0.0 3.3 19.1 43.8 
SKl-6 302 0.0 0.1 0.0 2.6 
305 31.3 16.9 1.4 19.3 
321 4.1 15.1 16.3 22.5 
323 2.9 16.0 27.7 137.9 
325 0.1 1.2 14.5 60.0 
SKl-9 304 0.0 0.1 0.0 0.0 
307 16.0 3.7 13.7 7.4 
310 0.0 0.0 0.0 0.0 
320 14.4 23.1 4.2 10.5 
324 0.0 0.1 2.6 1.0 
Appendix 8.2 
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Antibody response of individual calves to carbohydrate-protein 
antigen as measured by ELISA 
Vaccine Calf 
Group No. Day 0 Day 7 Day 14 Day 21 
PBSS 300 0.389 0.038 1.373 1.110 
312 0.432 0.285 0.694 0.877 
317 0.350 0.844 1.267 0.773 
319 0.540 0.907 0.764 0.617 
H15 0.465 0.193 0.402 0.759 
Live 303 0.356 0.796 1.444 1.685 
313 0.462 0.690 1.109 1.142 
SKl-1 299 0.407 0.726 1.680 1.585 
301 0.497 0.966 2.196 2.316 
309 0.727 0.698 1.882 1.813 
314 0.284 0.572 0.746 0.612 
322 0.628 1.103 1.367 1.315 
SKl-6 302 0.350 0.408 0.892 1.336 
305 0.308 0.202 1.658 1.422 
321 0.262 0.672 0.336 0.840 
323 0.167 0.017 0.596 0.663 
325 0.498 0.269 0.478 1.207 
SKl-9 304 0.242 0.101 0.722 0.767 
307 0.538 0.380 0.432 0.510 
310 0.284 0.193 1.082 0.846 
320 0.661 0.458 0.327 0.053 
324 0.372 0.225 0.644 0.268 
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Antibody response of individual calves to leukotoxin as measured 
by visual leukotoxin-neutralization assay 
Vaccine Calf 
Group No. Day 0 Day 7 Day 14 Day 21 
Live 303 8 8 .16 16 
313 4 4 64 64 
PBSS 300 4 2 2 4 
312 <2 <2 <2 <2 
317 <2 <2 <2 4 
319 <2 <2 <2 4 
H15 2 2 4 8 
SKl-1 299 <8 4 2 4 
301 <4 4 2 4 
309 <2 <2 <2 2 
314 <2 <2 <2 <2 
322 <2 <2 2 4 
SKl-6 302 <2 <2 <2 <2 
305 2 <2 <2 ·<2 
321 <2 <2 <2 2 
323 <2 <2 <2 2 
325 4 2 2 4 
SKl-9 304 2 2 2 2 
307 4 4 2 8 
310 4 4 2 2 
320 <2 <2 <2 2 
324 <2 <2 4 4 
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Lesion scores of calves following challenge 
with Pasteurel/a haemolytica A 1 
Vaccine Calf Lesion Mean 
Group No. Score ± SD 
Live 303 3.0 2.3 
313 1.5 ± 0.8 
PBSS 300 20.0 15.0 
312 20.0 ± 7.0 
317 13.5 
319 3.5 
H15 18.0 
SKl-1 299 3.0 5.3 
301 7.0 ± 2.1 
309 4.0 
314 8.0 
322 4.5 
SKl-6 302 20.0 9.4 
305 11.5 ± 6.7 
321 7.0 
323 2.5 
325 6.0 
SKl-9 304 9.0 12.2 
307 13.0 ± 4.1 
310 17.0 
320 7.0 
324 15.0 
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Mean peak area of antibody to OMPs for each vaccine group 
Vaccine Group 
Band MW SKl-1 SKl-6 SKl-9 PBS Live 
(kDa) {n=5) {n=5) (n=5) (n=5) (n-2) 
84.5 0.006 0.077 0.004 0.000 0.010 
± 0.002 ± 0.146 ± 0.002 ± 0.000 ± 0.003 
72.0 0.301 0.073 0.004 0.000 0.000 
± 0.313 ± 0.159 ±: 0.004 ± 0.000 ± 0.000 
64.5 0.000 0.000 0.140 0.076 0.271 
± 0.000 ± 0.000 ± 0.189 ± 0.164 ± 0.376 
61.0 0.219 0.085 0.003 0.003 0.001 
± 0.239 ± 0.103 ± 0.002 ± 0.003 ± 0.001 
57.0 0.209 0.000 0.004 0.001 0.159 
± 0.262 ± 0.000 ± 0.002 ± 0.002 ± 0.072 
50.5 0.075 0.110 0.001 0.109 0.003 
± 0.081 ± 0.153 ± 0.002 ± 0.026 ± 0.004 
45.5 0.269 0.075 0.140 0.102 0.095 
± 0.410 ± 0.096 ± 0.189 ± 0.127 ± 0.127 
41.0 0.234 0.000 0.000 0.000 0.101 
± 0.504 ± 0.000 ± 0.000 ± 0.000 ± 0.135 
37.0 0.141 0.126 0.001 0.001 0.005 
± 0.151 ± 0.113 ± 0.002 ± 0.002 ± 0.000 
32.0 0.064 0.072 0.116 0.000 0.010 
± 0.117 ± 0.010 ± 0.023 ± 0.000 ± 0.000 
27.0 0.000 0.107 0.005 0.000 0.003 
± 0.000 ± 0.158 ± 0.006 ± 0.000 ± 0.004 
16.5 0.069 0.082 0.000 0.000 0.005 
± 0.100 ± 0.123 ± 0.000 ± 0.000 ± 0.000 
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